BR0109192A - Tratamento de hipertensão ocular e glaucoma. - Google Patents

Tratamento de hipertensão ocular e glaucoma.

Info

Publication number
BR0109192A
BR0109192A BR0109192-1A BR0109192A BR0109192A BR 0109192 A BR0109192 A BR 0109192A BR 0109192 A BR0109192 A BR 0109192A BR 0109192 A BR0109192 A BR 0109192A
Authority
BR
Brazil
Prior art keywords
glaucoma
treatment
ocular hypertension
prostaglandin
related compound
Prior art date
Application number
BR0109192-1A
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/730,830 external-priority patent/US20010034355A1/en
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of BR0109192A publication Critical patent/BR0109192A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"TRATAMENTO DE HIPERTENSãO OCULAR E GLAUCOMA". é descrito um tratamento de hipertensão ocular e glaucoma através de terapia a longo prazo com um composto relacionado à prostaglandina para eliminação ou redução de pigmentação potencial da íris. A composição útil para o tratamento e uso do composto relacionado à prostaglandina para a produção da composição são também descritos.
BR0109192-1A 2000-03-16 2001-03-15 Tratamento de hipertensão ocular e glaucoma. BR0109192A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52757300A 2000-03-16 2000-03-16
US09/730,830 US20010034355A1 (en) 2000-03-16 2000-12-07 Treatment of ocular hypertension
PCT/JP2001/002035 WO2001068072A2 (en) 2000-03-16 2001-03-15 Composition for use in treatment of ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
BR0109192A true BR0109192A (pt) 2003-05-27

Family

ID=27062443

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109192-1A BR0109192A (pt) 2000-03-16 2001-03-15 Tratamento de hipertensão ocular e glaucoma.

Country Status (18)

Country Link
US (1) US20010056104A1 (pt)
EP (1) EP1272194A2 (pt)
JP (1) JP2003526660A (pt)
KR (1) KR20080012407A (pt)
CN (1) CN100506232C (pt)
AR (1) AR029818A1 (pt)
AU (2) AU2001241143B2 (pt)
BR (1) BR0109192A (pt)
CA (1) CA2402597C (pt)
CZ (1) CZ20023092A3 (pt)
HU (1) HUP0300391A3 (pt)
IL (1) IL151683A0 (pt)
MX (1) MXPA02008967A (pt)
NO (1) NO20024381L (pt)
NZ (1) NZ521325A (pt)
RU (1) RU2002127733A (pt)
TW (1) TWI286932B (pt)
WO (1) WO2001068072A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL124620A0 (en) † 1995-12-18 1998-12-06 Myriad Genetics Inc Chromosome 13-linked breast cancer susceptibility gene
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
EP1411950A2 (en) * 2001-07-31 2004-04-28 Sucampo AG Treatment of ocular hypertension and glaucoma
AU2003215820A1 (en) * 2002-03-28 2003-10-13 Sucampo Ag Method for treating ocular hypertension and glaucoma

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE82499T1 (de) * 1987-09-18 1992-12-15 R Tech Ueno Ltd Okulare hypotensivagenzien.
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
WO1990002553A1 (en) * 1988-09-06 1990-03-22 Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
WO1997023225A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US6232344B1 (en) * 1997-12-22 2001-05-15 Alcon Laboratories, Inc. 13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension
ATE245451T1 (de) * 1998-04-07 2003-08-15 Alcon Lab Inc Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen

Also Published As

Publication number Publication date
US20010056104A1 (en) 2001-12-27
JP2003526660A (ja) 2003-09-09
HUP0300391A2 (hu) 2003-06-28
AR029818A1 (es) 2003-07-16
KR20080012407A (ko) 2008-02-11
WO2001068072A3 (en) 2002-06-06
AU2001241143B2 (en) 2005-08-25
WO2001068072A2 (en) 2001-09-20
IL151683A0 (en) 2003-04-10
AU4114301A (en) 2001-09-24
CA2402597C (en) 2011-04-26
NZ521325A (en) 2004-05-28
CA2402597A1 (en) 2001-09-20
CN1429112A (zh) 2003-07-09
NO20024381D0 (no) 2002-09-13
EP1272194A2 (en) 2003-01-08
TWI286932B (en) 2007-09-21
MXPA02008967A (es) 2003-02-12
NO20024381L (no) 2002-11-15
CZ20023092A3 (cs) 2003-05-14
HUP0300391A3 (en) 2008-05-28
RU2002127733A (ru) 2004-03-27
CN100506232C (zh) 2009-07-01

Similar Documents

Publication Publication Date Title
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
FI954131A (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
GB0108591D0 (en) Therapeutic agents
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
FI972580A0 (fi) Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi
CY1115759T1 (el) Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου
SE9604786D0 (sv) New compounds
DK1514548T3 (da) Topisk ophthalmisk fluprostenol-præparat til behandling af glaukom og okulær hypertension
BR9507917A (pt) Reagente para preparar um agente radiofarmacêutico agente formador de imagem processo para preparar o mesmo kit para preparar uma preparação farmacêutica uso do reagente agente radioterapêutico composição e agente radiofarmacêutico
BR0209709A (pt) Composições hipotensivas de lipìdio e timolol e métodos de uso das mesmas
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
DK0687266T3 (da) Heterocykliske forbindelser og deres fremstilling og anvendelse
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
BR0116481A (pt) Compostos de heterociclilalquilindol ou azaindol como ligandos de 5-hidroxitriptamina-6
NO942610D0 (no) Heterosykliske forbindelser og deres fremstilling og anvendelse
BR0210238A (pt) Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma
DE3872701T2 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
RS8504A (en) Novel cyclohexil sulphones
ATE201677T1 (de) 4-imidomethyl-1-(2'-phenyl-2-oxoethyl)-piperidi e als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung
BR0109192A (pt) Tratamento de hipertensão ocular e glaucoma.
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
BR0215172A (pt) Derivados de benzodifuranimidazolina e benzofuranimidazolina e seu emprego para o tratamento de glaucoma
ATE337002T1 (de) Topische behandlung zur vorbeugung von augeninfektionen

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]